Hemoglobin levels and 30-day mortality in patients after myocardial infarction

被引:70
作者
Lipsic, E
van der Horst, ICC
Voors, AA
van der Meer, P
Nijsten, MWN
van Gilst, WH
van Veldhuisen, DJ
Zijlstra, F
机构
[1] Univ Groningen Hosp, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Clin Pharmacol, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Internal Med, NL-9713 EZ Groningen, Netherlands
关键词
myocardial infarction; hemoglobin; 30-day mortality;
D O I
10.1016/j.ijcard.2004.10.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia is an independent risk factor for cardiovascular (CV) outcomes in patients with coronary artery disease and heart failure. However, the effect of hemoglobin levels on short-term CV mortality in patients with acute myocardial infarction (MI) remains unclear. Methods: In a retrospective study we analyzed 1841 consecutive patients admitted with the diagnosis of acute MI. The primary end-point of the study was 30-day mortality. Patients were categorized according to the hemoglobin level on admission (10 g/dl or less, or greater than 10 g/dl). Results: The overall 30-day mortality was 10.3%. The mortality was 21.6% in patients with hemoglobin levels on admission <= 10 g/dl and 9.3% in patients with hemoglobin levels > 10 g/dl (p < 0.001). Multivariate logistic regression analysis showed, that lower hemoglobin concentration is an independent predictor of 30-day mortality, when adjusted for other risk factors (HR 1.76, CI 1.08-2.85; p = 0.02). Conclusions: Lower levels of hemoglobin are associated with higher short-term mortality in patients with acute MI. Specific therapeutic strategies in anemic patients with MI should be further considered. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 26 条
[1]   Effect of anemia on 1-year mortality in patients with acute myocardial infarction [J].
Al Falluji, N ;
Lawrence-Nelson, J ;
Kostis, JB ;
Lacy, CR ;
Ranjan, R ;
Wilson, AC .
AMERICAN HEART JOURNAL, 2002, 144 (04) :636-641
[2]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[3]  
Alvarez G, 2001, CRIT CARE, V5, P56
[4]   Hematocrit and the risk of coronary heart disease mortality [J].
Brown, DW ;
Giles, WH ;
Croft, JB .
AMERICAN HEART JOURNAL, 2001, 142 (04) :657-663
[5]   Effect of anaemia and cardiovascular disease on surgical mortality and morbidity [J].
Carson, JL .
LANCET, 1996, 348 (9034) :1055-1060
[6]   Perioperative blood transfusion and postoperative mortality [J].
Carson, JL ;
Duff, A ;
Berlin, JA ;
Lawrence, VA ;
Poses, RM ;
Huber, EC ;
O'Hara, DA ;
Noveck, H ;
Strom, BL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (03) :199-205
[7]   Nitric oxide and iron proteins [J].
Cooper, CE .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :290-309
[8]   Efficacy of recombinant human erythropoietin in critically ill patients - A randomized controlled trial [J].
Corwin, HL ;
Gettinger, A ;
Pearl, RG ;
Fink, MP ;
Levy, MM ;
Shapiro, MJ ;
Corwin, MJ ;
Colton, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22) :2827-2835
[9]  
Freudenberger Ronald S, 2003, Curr Opin Crit Care, V9, P356, DOI 10.1097/00075198-200310000-00004
[10]   HEMATOCRIT AND THE RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY - A 34-YEAR FOLLOW-UP [J].
GAGNON, DR ;
ZHANG, TJ ;
BRAND, FN ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1994, 127 (03) :674-682